Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
RDNT 
RadNet Inc (RDNT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: RDNT (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $73.71
1 Year Target Price $73.71
| 5 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 136.56% | Avg. Invested days 65 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.29B USD | Price to earnings Ratio - | 1Y Target Price 73.71 |
Price to earnings Ratio - | 1Y Target Price 73.71 | ||
Volume (30-day avg) 7 | Beta 1.43 | 52 Weeks Range 45.00 - 93.65 | Updated Date 08/15/2025 |
52 Weeks Range 45.00 - 93.65 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date 2025-08-10 | When - | Estimate 0.1557 | Actual 0.31 |
Profitability
Profit Margin -0.78% | Operating Margin (TTM) 7.12% |
Management Effectiveness
Return on Assets (TTM) 1.55% | Return on Equity (TTM) 1.74% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 6269730801 | Price to Sales(TTM) 2.77 |
Enterprise Value 6269730801 | Price to Sales(TTM) 2.77 | ||
Enterprise Value to Revenue 3.29 | Enterprise Value to EBITDA 21.07 | Shares Outstanding 76916096 | Shares Floating 69133695 |
Shares Outstanding 76916096 | Shares Floating 69133695 | ||
Percent Insiders 12.73 | Percent Institutions 90.12 |
Upturn AI SWOT
RadNet Inc
Company Overview
History and Background
RadNet Inc. was founded in 1983. It has grown through acquisitions to become a national leader in outpatient imaging services, focusing on high-quality, cost-effective diagnostic solutions.
Core Business Areas
- Diagnostic Imaging Services: Provides a full range of diagnostic imaging services, including MRI, CT, PET, mammography, ultrasound, and X-ray. Services are delivered through a network of owned and operated outpatient imaging centers.
- Managed Care: Manages radiology benefits for health plans and other risk-bearing organizations.
- Technology Solutions: Offers technology solutions such as eRAD RIS/PACS (Radiology Information System/Picture Archiving and Communication System).
Leadership and Structure
Howard Berger serves as the Chairman and CEO. The company operates with a corporate structure overseeing regional divisions, each managing a portfolio of imaging centers.
Top Products and Market Share
Key Offerings
- MRI (Magnetic Resonance Imaging): High-resolution imaging for diagnosing a wide range of conditions. Competitors include hospital-based radiology departments and other outpatient imaging chains. RadNet's market share is estimated to be around 6-7% of the overall US MRI market. Revenue not publicly broken out for each modality, estimated at 25% of imaging revenue
- CT (Computed Tomography): Detailed cross-sectional imaging. Competitors include hospital-based radiology departments and other outpatient imaging chains. RadNet's market share is estimated to be around 6-7% of the overall US CT market. Revenue not publicly broken out for each modality, estimated at 20% of imaging revenue
- PET/CT (Positron Emission Tomography/Computed Tomography): Advanced imaging for oncology and other applications. Competitors are mostly hospital-based centers, with a smaller number of outpatient centers.
Market Dynamics
Industry Overview
The diagnostic imaging industry is characterized by increasing demand driven by an aging population, technological advancements, and a shift towards outpatient settings. Reimbursement pressures and regulatory compliance are key challenges.
Positioning
RadNet is a leading independent provider of outpatient imaging services, with a focus on large, densely populated markets. Its competitive advantages include scale, operational efficiency, and a comprehensive service offering.
Total Addressable Market (TAM)
The TAM for diagnostic imaging in the U.S. is estimated to be $100 billion annually. RadNet's position is to capture a larger share through organic growth and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Extensive network of outpatient imaging centers
- Strong relationships with referring physicians
- Advanced technology infrastructure
- Experienced management team
- Geographic diversity
Weaknesses
- High debt levels
- Exposure to reimbursement pressures
- Dependence on acquisitions for growth
- Complex regulatory environment
- Potential for equipment obsolescence
Opportunities
- Further consolidation of the outpatient imaging market
- Expansion into new geographic markets
- Increased utilization of advanced imaging modalities
- Growth in managed care partnerships
- Development of new technology solutions
Threats
- Reductions in Medicare and private payer reimbursement rates
- Increased competition from hospital-based imaging centers
- Changes in healthcare regulations
- Technological disruptions
- Economic downturns
Competitors and Market Share
Key Competitors
- HQY
- MGLN
- USPH
Competitive Landscape
RadNet competes with hospital-based imaging centers and other outpatient imaging providers. RadNet's advantages include its scale, operational efficiency, and focus on outpatient settings. Competitors may have advantages in brand recognition or access to capital.
Major Acquisitions
White Oak Imaging
- Year: 2022
- Acquisition Price (USD millions): 18
- Strategic Rationale: Expansion into new geographic markets.
Growth Trajectory and Initiatives
Historical Growth: RadNet has grown both organically and through acquisitions, expanding its network of imaging centers and service offerings.
Future Projections: Analysts project continued revenue growth, driven by increasing demand for imaging services and further consolidation of the market.
Recent Initiatives: Recent strategic initiatives include expanding into new markets, investing in advanced technology, and strengthening relationships with managed care providers.
Summary
RadNet is a leading outpatient imaging provider with a strong network. Its growth is driven by acquisitions and increasing demand. Challenges include high debt and reimbursement pressures. Continued success depends on efficient operations and strategic acquisitions.
Peer Comparison
Sources and Disclaimers
Data Sources:
- RadNet Inc. SEC Filings (10-K, 10-Q), Investor Presentations, Industry Reports, Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About RadNet Inc
Exchange NASDAQ | Headquaters Los Angeles, CA, United States | ||
IPO Launch date 1986-07-01 | Chairman, President & CEO Dr. Howard G. Berger M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 11000 | Website https://www.radnet.com |
Full time employees 11000 | Website https://www.radnet.com | ||
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.